iProtean, now part of Veralon—Managing Risk

I’ve been working in healthcare finance for about 26 years and I can’t think of another time when we had this level of risk within the industry. (Eric Jordahl, Kaufman, Hall & Associates)   A phrase commonly heard in many industries—risk management—migrated to the healthcare industry several years ago. But the financial crisis has moved […]

Why is Kaiser/Geisinger Such a Big Deal?

by John Harris, Managing Director
and Danielle Bangs, Principal

Open PDF file >

A colleague asked, “Why is the Kaiser/Geisinger announcement such a big deal? There have been a lot of mega mergers.” An excellent question. This was more than just a $95B insurer/health system acquiring a $7B one. Here’s why: Kaiser Permanente has long been recognized as an iconic leader in value-based care, but they have largely […]

Making the Business Case for Healthcare M&A: Top 5 Reasons

by Daniel M. Grauman, Managing Director & CEO
and Danielle Bangs, Principal

Open PDF file >

Seventy percent of healthcare executives expect more mergers and acquisitions across healthcare sectors in 2022, a KPMG survey found, while 30 percent of healthcare investors plan to increase deal activity by 10 percent or more. For hospital and health system leaders, it’s a good time to consider: What’s your business case for M&A? We’ve seen […]

Podcast: Physician Practice Mergers and Acquisitions – Trends in the Health Care Industry

by Daniel M. Grauman, Managing Director & CEO
Podcast

Host Ericka Adler, Roetzel shareholder and Health Law Practice Group Leader, is joined by fellow Roetzel shareholder David Hochman, and special guest Dan Grauman, Veralon Managing Director and CEO, to discuss evaluating and planning for healthcare practice mergers and acquisitions. Dan Grauman talks about the ongoing trends of consolidation he sees in healthcare, the important […]

What’s Your Post-Merger Financial Outlook? Why a Pre-Merger Gut Check Is Critical

by Danielle Bangs, Principal

Open PDF file >

One of the most important considerations in finalizing a healthcare merger is how well the consolidated entity will perform, financially, after the deal is complete. Many times, leaders get so caught up in the blocking-and-tackling of due diligence—a time-consuming exercise that protects their organization from material risk—that their ability to see past the point of […]

Magnitude of Financial Pressures Demands Fast, Actionable Financial Planning

by J. David Robeson, III, Principal
and Ross Shuster, Manager

Open PDF file >

Yet again, the latest Omicron surge delivered a financial punch to hospitals and health systems across the country, with many organizations experiencing one of their worst quarters ever this year. Now, healthcare leaders must take a fresh look at their financial planning process to determine their way forward in a turbulent environment. When the highly […]

Beyond ‘Shark Tank’: Applying Healthcare Valuation Multiples Is Harder than It Seems

by Daniel M. Grauman, Managing Director & CEO
and Jessica E. Stack, Principal

Open PDF file >

It’s a familiar scene from a blockbuster show: A billionaire investor sizes up a company by dividing the value of the company by its annual profit to find the multiple. It’s a metric used to assess the market value of an asset, and in the world of “Shark Tank,” it comes to investors quickly and […]

Anatomy of a Deal Series No. 5:
After the Deal Is Over: What Hospital Integration Looks Like

by Daniel M. Grauman, Managing Director & CEO

Open PDF file >

The devil is in the details. A year after the merger of Independent Hospital (IHX) and Regional Health System (RHS), the work of integrating these facilities is still underway. Some aspects of integration, such as reviewing group purchasing contracts, food services agreements, opportunities to consolidate back-office functions and more, have been relatively easy to complete. […]

Anatomy of a Deal Series No. 4:
Navigating the Due Diligence Process

by Daniel M. Grauman, Managing Director & CEO

Open PDF file >

Once the matchmaking aspect of a healthcare M&A is complete and the parties involved agree on what partnership might look like, the next step is due diligence. Performing due diligence can seem like a “check the boxes” exercise—but it’s much more than that. It’s an opportunity to explore the strategic implications of a proposed merger […]